Age: 63.0
Sex: U
Vaccine: COVID19, TDAP
Symptoms: Pustule, Rash, Rash pustular, Scar, Skin discolouration
Clinical narrative: Pustulosis; Red welt; scarring on face; erruption; discolouration on my face; Covid pustulosis / pustule on my face, my neck, my chest, my arm and i have them on my parts of my legs and my trunk; This non-serious case was reported by a other health professional via other manufacturer and described the occurrence of pustular rash in a adult patient who received DTPa (Reduced antigen) (Boostrix) (batch number X357E) for prophylaxis.   Co-suspect products included Tozinameran (Comirnaty) (batch number Lm2215) for prophylaxis.   The patient's past medical history included pain in arm and hormone replacement therapy. Previously administered products included COVID-19 vaccine (received 1st dose of pfizer12yr+ Covid-19 Bivalent on 20 march 2023 with lot number GJ3274 by intramuscular route in left arm of dose 0.3 ml) and COVID-19 vaccine (received 2nd dose of Pfizer 2023-24 Covid 12yr+SYR on 05 october 2023 with lot number HG4677 by intramuscular route in left arm of dose 0.3 ml). Concurrent medical conditions included hypercalciuria, recurrent urinary tract infection (more than 20 year ago), vitamin d deficiency and drug allergy (Diuretics, Doxepin, Gabapentin). Concomitant products included estradiol;estriol;progesterone;vitamin E nos (Phytob L 4x), estradiol, methenamine, colecalciferol (Vitamin D3) and phosphorus.   On 05-SEP-2024, the patient received Boostrix (intramuscular, left arm) .5 ml and the 3rd dose of Comirnaty (intramuscular, right arm) .3 ml. On an unknown date, an unknown time after receiving Boostrix, the patient experienced pustular rash (Verbatim: Pustulosis), erythema urticarial (Verbatim: Red welt), scar (Verbatim: scarring on face), eruption facial (Verbatim: erruption), skin discoloration (Verbatim: discolouration on my face) and pustule (Verbatim: Covid pustulosis / pustule on my face, my neck, my chest, my arm and i have them on my parts of my legs and my trunk). The outcome of the pustular rash, erythema urticarial, scar, eruption facial, skin discoloration and pustule were not resolved.   It was unknown if the reporter considered the pustular rash, erythema urticarial, scar, eruption facial, skin discoloration and pustule to be related to Boostrix.     It was unknown if the company considered the pustular rash, erythema urticarial, scar, eruption facial, skin discoloration and pustule to be related to Boostrix.   Additional Information: GSK Receipt Date: 18-DEC-2024 The patient received Boostrix and Comirnaty on the same day and the reporter reported that it was difficult to say at this point that there was any permanent damage, possible scarring on face occur. Patient was still getting the eruption and had discoloration on face where they had appears. Patient had red welts that morphed into a welt with a pustule on the top of it, it did not go away and covid pustulosis /pustule on face, neck, chest, arm and had them on parts of legs and trunk. It was unknown if the reporter considered the pustular rash, erythema urticarial, scar, eruption facial, skin discoloration and pustule to be related to Comirnaty.